Koumans Emilia H, Harrison Ayanna, House L Duane, Burley Kim, Ruffo Nan, Smith Ruben, FitzHarris Lauren, Johnson Christopher H, Taylor Allan W, Nesheim Steven R
1 Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.
2 DB Consulting Group, Inc., Atlanta, GA, USA.
Int J STD AIDS. 2018 Oct;29(12):1225-1233. doi: 10.1177/0956462418780053. Epub 2018 Jul 4.
The Centers for Disease Control and Prevention and the American Congress of Obstetricians and Gynecologists recommend universal prenatal HIV testing to prevent perinatal HIV transmission in the U.S.; since the 1990s perinatal HIV transmission has declined. In 2006, 74% of women with a recent live birth reported testing for HIV prenatally or at delivery. We used Pregnancy Risk Assessment Monitoring System data from 36 states and New York City from 2004 to 2013 (N = 387,424) to assess characteristics associated with lack of self-reported testing and state-to-state variability in these associations. Overall, 75.2% (95% confidence interval [CI] 75.0-75.5) of women with a recent live birth reported an HIV test. There were significant differences in testing prevalence by state, ranging from 91.8% (95% CI 91.0-92.6) in New York to 42.3% (95% CI 41.7-43.5) in Utah. In adjusted analysis, characteristics associated with no reported testing included being married, white, non-Hispanic, multiparous, not smoking during pregnancy, and having neither Medicaid nor Special Supplemental Nutritional Program for Women, Infants, and Children. White married women were 57% (adjusted prevalence ratio [aPR] 1.57, 95% CI 1.52-1.63) more likely to report no test compared to white unmarried women. Multiparous married women were 57% (aPR 1.57, 95% CI 1.51-1.64) more likely to report no test compared to multiparous unmarried women. Women who were married, white, non-Hispanic, and multiparous women were 23% less likely to be tested than other women combined. Marital status was significantly associated with lower prevalence of testing in 35 of the 37 reporting areas, and race was significant in 30 of 35 states with race information. The prevalence of reported HIV testing during pregnancy or at delivery remains below 80%. Opportunities exist to increase HIV testing among pregnant women, particularly among certain subpopulations.
美国疾病控制与预防中心以及美国妇产科学会建议进行普遍的产前艾滋病毒检测,以预防美国的围产期艾滋病毒传播;自20世纪90年代以来,围产期艾滋病毒传播率有所下降。2006年,74%有近期活产的妇女报告在产前或分娩时进行了艾滋病毒检测。我们使用了2004年至2013年来自36个州和纽约市的妊娠风险评估监测系统数据(N = 387,424),以评估与未自我报告检测相关的特征以及这些关联在州与州之间的差异。总体而言,75.2%(95%置信区间[CI] 75.0 - 75.5)有近期活产的妇女报告进行了艾滋病毒检测。各州的检测患病率存在显著差异,从纽约的91.8%(95% CI 91.0 - 92.6)到犹他州的42.3%(95% CI 41.7 - 43.5)。在调整分析中,与未报告检测相关的特征包括已婚、白人、非西班牙裔、经产妇、孕期不吸烟,以及既没有医疗补助也没有妇女、婴儿和儿童特别补充营养计划。与未婚白人妇女相比,已婚白人妇女报告未检测的可能性高57%(调整患病率比[aPR] 1.57,95% CI 1.52 - 1.63)。与经产妇未婚妇女相比,经产妇已婚妇女报告未检测的可能性高57%(aPR 1.57,95% CI 1.51 - 1.64)。已婚、白人、非西班牙裔和经产妇妇女接受检测的可能性比其他妇女的总和低23%。婚姻状况在37个报告地区中的35个地区与较低的检测患病率显著相关,在有种族信息的35个州中的30个州,种族与检测患病率显著相关。孕期或分娩时报告的艾滋病毒检测患病率仍低于80%。存在增加孕妇艾滋病毒检测的机会,特别是在某些亚人群中。